Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 9—September 2024
Synopsis

Onward Virus Transmission after Measles Secondary Vaccination Failure

Isaac TranterComments to Author , Nicolas Smoll, Colleen L. Lau, Dusty-Lee Williams, Deborah Neucom, Donna Barnekow, and Amalie Dyda
Author affiliations: University of Queensland, Herston, Queensland, Australia (I. Trantner, N. Smoll, C.L. Lau, A. Dyda); Sunshine Coast Hospital and Health Service, Maroochydore, Queensland, Australia (N. Smoll, D.-L. Williams, D. Neucom, D. Barnekow)

Main Article

Figure 1

Flowchart of retrieved, excluded, and included items during systemic review of cases of onward virus transmission after measles SVF, as of March 31, 2023 (15). SVF, secondary vaccination failure.

Figure 1. Flowchart of retrieved, excluded, and included items during systemic review of cases of onward virus transmission after measles SVF, as of March 31, 2023 (15). SVF, secondary vaccination failure.

Main Article

References
  1. World Health Organization. Measles. 2024 Jul 12 [cited 2024 Aug 1]. https://www.who.int/news-room/fact-sheets/detail/measles
  2. Patel  MK, Goodson  JL, Alexander  JP Jr, Kretsinger  K, Sodha  SV, Steulet  C, et al. Progress toward regional measles elimination—worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69:1700–5. DOIPubMedGoogle Scholar
  3. Anders  JF, Jacobson  RM, Poland  GA, Jacobsen  SJ, Wollan  PC. Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J. 1996;15:62–6. DOIPubMedGoogle Scholar
  4. Fappani  C, Gori  M, Canuti  M, Terraneo  M, Colzani  D, Tanzi  E, et al. Breakthrough infections: a challenge towards measles elimination? Microorganisms. 2022;10:1567. DOIPubMedGoogle Scholar
  5. Hubiche  T, Brazier  C, Vabret  A, Reynaud  S, Roudiere  L, Del Giudice  P. Measles transmission in a fully vaccinated closed cohort: data from a nosocomial clustered cases in a teenage psychiatric unit. Pediatr Infect Dis J. 2019;38:e230–2. DOIPubMedGoogle Scholar
  6. Arima  Y, Oishi  K. Letter to the editor: measles cases among fully vaccinated persons. Euro Surveill. 2018;23:1800449.
  7. Markowitz  LE, Preblud  SR, Fine  PE, Orenstein  WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990;9:101–10. DOIPubMedGoogle Scholar
  8. Gastañaduy  PA, Clemmons  N, Redd  SB, Clemmons  NK, Lee  AD, Hickman  CJ, et al. Measles [chapter 7]. In: Roush SW, Baldy LM, editors. Manual for the surveillance of vaccine-preventable diseases. Atlanta: Centers for Disease Control and Prevention; 2019 [cited 2024 May 16]. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html
  9. Mercader  S, Garcia  P, Bellini  WJ. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol. 2012;19:1810–7. DOIPubMedGoogle Scholar
  10. Javelle  E, Colson  P, Parola  P, Raoult  D. Measles, the need for a paradigm shift. Eur J Epidemiol. 2019;34:897–915. DOIPubMedGoogle Scholar
  11. Seto  J, Ikeda  T, Tanaka  S, Komabayashi  K, Matoba  Y, Suzuki  Y, et al. Detection of modified measles and super-spreader using a real-time reverse transcription PCR in the largest measles outbreak, Yamagata, Japan, 2017 in its elimination era. Epidemiol Infect. 2018;146:1707–13. DOIPubMedGoogle Scholar
  12. Kurata  T, Kanbayashi  D, Egawa  K, Kinoshita  M, Yoshida  H, Miyazono  M, et al. A measles outbreak from an index case with immunologically confirmed secondary vaccine failure. Vaccine. 2020;38:1467–75. DOIPubMedGoogle Scholar
  13. Sundell  N, Dotevall  L, Sansone  M, Andersson  M, Lindh  M, Wahlberg  T, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill. 2019;24:1900114. DOIPubMedGoogle Scholar
  14. Gastañaduy  PA, Funk  S, Lopman  BA, Rota  PA, Gambhir  M, Grenfell  B, et al. Factors associated with measles transmission in the United States during the postelimination era. JAMA Pediatr. 2020;174:56–62. DOIPubMedGoogle Scholar
  15. Liberati  A, Altman  DG, Tetzlaff  J, Mulrow  C, Gøtzsche  PC, Ioannidis  JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. DOIPubMedGoogle Scholar
  16. Gostic  KM, McGough  L, Baskerville  EB, Abbott  S, Joshi  K, Tedijanto  C, et al. Practical considerations for measuring the effective reproductive number, Rt. PLOS Comput Biol. 2020;16:e1008409. DOIPubMedGoogle Scholar
  17. Jones  J, Klein  R, Popescu  S, Rose  K, Kretschmer  M, Carrigan  A, et al. Lack of measles transmission to susceptible contacts from a health care worker with probable secondary vaccine failure—Maricopa County, Arizona, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:832–3. DOIPubMedGoogle Scholar
  18. Rosen  JB, Rota  JS, Hickman  CJ, Sowers  SB, Mercader  S, Rota  PA, et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis. 2014;58:1205–10. DOIPubMedGoogle Scholar
  19. Zhang  Z, Chen  M, Ma  R, Pan  J, Suo  L, Lu  L. Outbreak of measles among persons with secondary vaccine failure, China, 2018. Hum Vaccin Immunother. 2020;16:358–62. DOIPubMedGoogle Scholar
  20. Avramovich  E, Indenbaum  V, Haber  M, Amitai  Z, Tsifanski  E, Farjun  S, et al. Measles outbreak in a highly vaccinated population—Israel, July–August 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1186–8. DOIPubMedGoogle Scholar
  21. Iwamoto  M, Hickman  CJ, Colley  H, Arciuolo  RJ, Mahle  CE, Deocharan  B, et al. Measles infection in persons with secondary vaccine failure, New York City, 2018-19. Vaccine. 2021;39:5346–50. DOIPubMedGoogle Scholar
  22. Santibanez  S, Prosenc  K, Lohr  D, Pfaff  G, Jordan Markocic  O, Mankertz  A. Measles virus spread initiated at international mass gatherings in Europe, 2011. Euro Surveill. 2014;19:6–15. DOIPubMedGoogle Scholar
  23. Gohil  SK, Okubo  S, Klish  S, Dickey  L, Huang  SS, Zahn  M. Healthcare workers and post-elimination era measles: lessons on acquisition and exposure prevention. Clin Infect Dis. 2016;62:166–72. DOIPubMedGoogle Scholar
  24. Edmonson  MB, Addiss  DG, McPherson  JT, Berg  JL, Circo  SR, Davis  JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 1990;263:2467–71. DOIPubMedGoogle Scholar
  25. Gibney  KB, Attwood  LO, Nicholson  S, Tran  T, Druce  J, Healy  J, et al. Emergence of attenuated measles illness among IgG-positive/IgM-negative measles cases: Victoria, Australia, 2008–2017. Clin Infect Dis. 2020;70:1060–7. DOIPubMedGoogle Scholar
  26. Hahné  SJM, Nic Lochlainn  LM, van Burgel  ND, Kerkhof  J, Sane  J, Yap  KB, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214:1980–6. DOIPubMedGoogle Scholar
  27. Rota  JS, Hickman  CJ, Sowers  SB, Rota  PA, Mercader  S, Bellini  WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204(Suppl 1):S559–63. DOIPubMedGoogle Scholar
  28. Bianchi  S, Gori  M, Fappani  C, Ciceri  G, Canuti  M, Colzani  D, et al. Characterization of vaccine breakthrough cases during measles outbreaks in Milan and surrounding areas, Italy, 2017–2021. Viruses. 2022;14:141068. DOIPubMedGoogle Scholar
  29. Paunio  M, Peltola  H, Valle  M, Davidkin  I, Virtanen  M, Heinonen  OP. Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol. 1998;148:1103–10. DOIPubMedGoogle Scholar
  30. Smith  J, Banu  S, Young  M, Francis  D, Langfeldt  K, Jarvinen  K. Public health response to a measles outbreak on a university campus in Australia, 2015. Epidemiol Infect. 2018;146:314–8. DOIPubMedGoogle Scholar
  31. Pacenti  M, Maione  N, Lavezzo  E, Franchin  E, Dal Bello  F, Gottardello  L, et al. Measles virus infection and immunity in a suboptimal vaccination coverage setting. Vaccines (Basel). 2019;7:199. DOIPubMedGoogle Scholar

Main Article

Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external